{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:29:15Z","timestamp":1782289755750,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jemermed.2020.02.019","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T17:19:18Z","timestamp":1585847958000},"page":"756-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hemophilia and von Willebrand Disease: A Review of Emergency Department Management"],"prefix":"10.1016","volume":"58","author":[{"given":"Collin","family":"Tebo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Mazer-Amirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2020.02.019_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jemermed.2007.12.024","article-title":"Emergency department care for patients with hemophilia and von Willebrand disease","volume":"39","author":"Singleton","year":"2010","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2020.02.019_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0038-1642697","article-title":"Molecular genetics of coagulation factor VIII gene and hemophilia A","volume":"74","author":"Antonarakis","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jemermed.2020.02.019_bib4","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchett","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jemermed.2020.02.019_bib5","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"issue":"suppl 2","key":"10.1016\/j.jemermed.2020.02.019_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2012.02796.x","article-title":"Management of bleeding disorders in children","volume":"18","author":"Berntorp","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/hae.13201","article-title":"Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctor\u2019s Organization (UKHCDO) guideline","volume":"23","author":"Hanley","year":"2017","journal-title":"Hemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1351-8216.2003.00822.x","article-title":"Iliopsoas haemorrhage in patients with bleeding disorders--experience from one centre","volume":"9","author":"Ashrani","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2516.2005.01123.x","article-title":"Iliopsoas haemorrhage in patients with haemophilia: results from one centre","volume":"11","author":"Balkan","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1542\/pir.34.7.289","article-title":"Hemophilia: in review","volume":"34","author":"Zimmerman","year":"2013","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.jemermed.2020.02.019_bib11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2516.2007.01546.x","article-title":"Utility of computed tomography of the head following head trauma in boys with haemophilia","volume":"13","author":"Witmer","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1365-2516.2003.00789.x","article-title":"Intracranial haemorrhage among a population of haemophilic patients in Brazil","volume":"9","author":"Antunes","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2516.2011.02720.x","article-title":"Management of muscle haematomas in patients with severe haemophilia in an evidence poor world","volume":"18","author":"Sorensen","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2516.2010.02380.x","article-title":"Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score","volume":"17","author":"Melchiorre","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib15","author":"National Hemophilia Foundation Medical and Scientific Advisory Council (MASAC)"},{"key":"10.1016\/j.jemermed.2020.02.019_bib16","article-title":"MASAC recommendations concerning products licensed for the treatment of hemophilia and other bleeding disorders","volume":"250","year":"2017","journal-title":"MASAC Document"},{"key":"10.1016\/j.jemermed.2020.02.019_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2040620717721458","article-title":"Current and emerging factor VIII replacement products for hemophilia A","volume":"8","author":"Cuifir","year":"2017","journal-title":"Ther Adv Hemotol"},{"key":"10.1016\/j.jemermed.2020.02.019_bib18","first-page":"441","article-title":"Guidelines for cryoprecipitate transfusion","volume":"49","author":"Droubatchevskaia","year":"2007","journal-title":"BC Med J"},{"key":"10.1016\/j.jemermed.2020.02.019_bib19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1365-2141.2002.03507.x","article-title":"DDAVP challenge tests in boys with mild\/moderate haemophilia A","volume":"117","author":"Revel-Vilk","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2020.02.019_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1067\/mpd.2002.123626","article-title":"Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease","volume":"140","author":"Gill","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jemermed.2020.02.019_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jemermed.2012.11.108","article-title":"Acquired hemophilia presenting as profound hematuria: evaluation, diagnosis, and management of elusive cause of bleeding in the emergency department setting","volume":"45","author":"Shander","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2020.02.019_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jemermed.2020.02.019_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Huth-Kuhne","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jemermed.2020.02.019_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of Von Willebrand disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jemermed.2020.02.019_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"Von Willebrand disease: evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib26","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/MD.0000000000003038","article-title":"A laboratory phenotype\/genotype correlation of 1167 French patients from 670 families with von Willebrand disease: a new epidemiologic picture","volume":"95","author":"Veyradier","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"suppl 2","key":"10.1016\/j.jemermed.2020.02.019_bib27","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","author":"Peyvandi","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jemermed.2020.02.019_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/1076029616675969","article-title":"a concise review and update for the practicing physician","volume":"23","author":"Swami","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jemermed.2020.02.019_bib29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.24195","article-title":"Bleeding spectrum in children with moderate or severe von Willebrand disease: relevance of pediatric-specific bleeding","volume":"9","author":"Sander","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jemermed.2020.02.019_bib30","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2020.02.019_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2012.09.002","article-title":"Hemophilic arthropathy in pateints with von Willebrand disease","volume":"26","author":"van Galen","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.jemermed.2020.02.019_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2002-27814","article-title":"Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications","volume":"28","author":"Michiels","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jemermed.2020.02.019_bib33","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jemermed.2020.02.019_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/MBC.0000000000000158","article-title":"Desmopressin responsiveness at a capped dose of 15 \u03bcg in type 1 von Willebrand disease and mild hemophilia A","volume":"25","author":"Siew","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jemermed.2020.02.019_bib35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/hae.12254","article-title":"Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders","volume":"20","author":"Leissinger","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1992.tb04598.x","article-title":"Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP)","volume":"82","author":"Mannucci","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2020.02.019_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0049-3848(93)90152-E","article-title":"Repeated infusions of DDAVP induce low response of FVIII and vWF but not of plasminogen activators","volume":"70","author":"Vicente","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.jemermed.2020.02.019_bib38","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/ndt\/gfu263","article-title":"Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series","volume":"29","author":"Achinger","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jemermed.2020.02.019_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/hae.12732","article-title":"Side effects of desmopressin in patients with bleeding disorders","volume":"22","author":"Stoof","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib40","series-title":"MASAC recommendations concerning products licensed for the treatment of hemophilia and other bleeding disorders","year":"2018"},{"key":"10.1016\/j.jemermed.2020.02.019_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1358\/dot.2016.52.12.2570978","article-title":"Recombinant von Willebrand factor: a first-of-its-kind product for von Willebrand disease","volume":"52","author":"Singal","year":"2016","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jemermed.2020.02.019_bib42","doi-asserted-by":"crossref","first-page":"100572","DOI":"10.1016\/j.blre.2019.04.001","article-title":"Evolution of replacement therapy for von Willebrand disease: from plasma fraction to recombinant von Willebrand factor","volume":"38","author":"Peyvandi","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.jemermed.2020.02.019_bib43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1182\/asheducation-2016.1.683","article-title":"New treatment approaches to von Willebrand disease","volume":"2016","author":"Lavin","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jemermed.2020.02.019_bib44","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1111\/hae.13051","article-title":"Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial","volume":"22","author":"Eghbali","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jemermed.2020.02.019_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and\u00a0oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2020.02.019_bib46","first-page":"CD011385","article-title":"Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or von Willebrand disease undergoing minor oral surgery or dental extractions","volume":"12","author":"van Galen","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467920301153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467920301153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:53Z","timestamp":1760028293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467920301153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0736467920301153"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2020.02.019","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemophilia and von Willebrand Disease: A Review of Emergency Department Management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2020.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}